Gonadotropin-releasing hormone analogue (GnRH-a) therapyReferencesCitations Wallach E, Vlahos NF (2004). Uterine myomas: An
overview of development, clinical features, and management. Obstetrics and Gynecology, 104(2): 393–406. Tierney R, et al. (2000). Menstrual blood loss measured
5 to 6 years after endometrial ablation. Obstetrics and Gynecology, 95(2): 251–254. Donnez J, et al. (2001). Goserelin acetate (Zoladex)
plus endometrial ablation for dysfunctional uterine bleeding: A 3-year
follow-up evaluation. Fertility and Sterility, 75(3):
620–622. Speroff L, Fritz MA (2005). Dysfunctional uterine
bleeding. In L Speroff, MA Fritz, eds., Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 548–571. Philadelphia:
Lippincott Williams and Wilkins. Mishell DR Jr, et al. (2001). Abnormal uterine
bleeding. In MA Stenchever et al., eds., Comprehensive Gynecology, 4th ed., pp. 1079–1097. St. Louis:
Mosby. Lethaby A, et al. (2002). Efficacy of pre-operative
gonadotropin hormone releasing analogues for women with uterine fibroids
undergoing hysterectomy or myomectomy: A systematic review. British Journal of Obstetrics and Gynaecology, 109(10):
1097–1108. Speroff L, Fritz MA (2005). The uterus. In
Clinical Gynecologic Endocrinology and Infertility, 7th
ed., pp. 113–144. Philadelphia: Lippincott Williams and Wilkins. American College of Obstetricians and Gynecologists
(2000). Surgical alternatives to hysterectomy in the management of leiomyomas.
ACOG Technical Bulletin No. 16. Obstetrics and Gynecology, 95(5): 1–9. Haney AF (2003). Leiomyomata. In JR Scott et al.,
eds., Danforth's Obstetrics and Gynecology, 9th ed., pp.
869–887. Philadelphia: Lippincott Williams and Wilkins. Lethaby A, Vollenhoven B (2006). Fibroids (uterine
myomatosis, leiomyomas). Online version of Clinical Evidence (15).
| |